Quince Therapeutics’ lead asset eDSP failed to meet the primary or secondary endpoints in the pivotal NEAT trial.

Topline results show eDSP failed to significantly improve RmICARS scores in ataxia-telangiectasia patients compared with placebo in the NEAT trial.

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.

Phase III trial successfully achieved its primary endpoint and key secondary endpoints with high statistical significance Levacetylleucine demonstrated clinically meaningful improvements in ...

The dog suddenly tilts its head, stumbles while walking, or seems disoriented. Some animals vomit, others lean against walls or can barely stand. Such abrupt changes alarm many dog owners and are ...

Spinocerebellar ataxia type 7 is a form of spinocerebellar ataxia, which is a clinically and genetically heterogeneous group of rare inherited neurodegenerative disorders. Among the spinocerebellar ...

Vitamin B6 deficiency can cause mental health symptoms, skin rashes, and sores, or cracks on the mouth or tongue. More serious symptoms of low B6 levels include anemia, nerve damage, and loss of ...

Scientists have uncovered a surprising genetic workaround that helps cells cope with Friedreich’s ataxia, a rare and devastating disorder. Credit: Shutterstock Scientists discovered that reducing a ...

With similar symptoms, it can be difficult to tell which illness is which. Here’s what to know. By Dani Blum Early clues suggest that this flu season could be particularly brutal. And while national ...

Florida wildlife officials have confirmed the state's second case of a deadly and highly contagious infection known as "zombie deer disease" in a wild deer. Columbia University Medical Center-led ...